SNSE/UNHCL (SNSE/UNHCL)

Santiago Stock Exchange: SNSE/UNHCL · CLP

CLP 399,500

+0.00 (0.0%)· Recorded snapshot

Market cap	361.8T
Revenue (ttm)	437.9T
Net income (ttm)	15.5T
EPS (ttm)	CLP 17,207
P/E (trailing)	23.2x
P/E (forward)	18.3x
Dividend	CLP 8,313 (2.08%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 437.9T
Net income (ttm): 15.5T
EPS (ttm): CLP 17,207
P/E (trailing): 23.2x
P/E (forward): 18.3x
Market cap: 361.8T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.3

P25 n/aP50 n/aP75 n/a

Trailing P/E23.2

P25 n/aP50 n/aP75 n/a

ROE15.8

P25 n/aP50 n/aP75 n/a

ROIC12.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SNSE/UNHCL indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-10-13
Employees	390,000
Employees change	-10,000
Employees growth	-2.5%
Enterprise value	CLP 410.8T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-08-17
Fiscal year end	December
Founded	1974
Industry	Healthcare Plans
Is primary listing	No
ISIN number	US91324P1021
Last earnings date	2026-10-13
Last refreshed	2026-10-28
Market cap	CLP 361.8T
Next earnings date	2027-01-12
Price	CLP 399,500.00
Price currency	CLP
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-27
Symbol	snse/UNHCL
Website	https://www.unitedhealthgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.39x
Average P/E ratio (3Y)	25.01x
Average P/E ratio (5Y)	24.72x
Earnings yield	4.31%
EV/Earnings	26.58x
EV/EBIT	15.88x
EV/EBITDA	13.71x
EV/FCF	18.5x
EV/Sales	0.93x
FCF / EV yield	5.41%
FCF yield	6.14%
Forward P/E	18.28x
Graham number	208657.14368
Graham upside	-47.77%
Lynch fair value	CLP 85,324.37
Lynch upside	-78.64%
P/(FCF - SBC) ratio	17.05x
P/(OCF - SBC) ratio	14.77x
P/B ratio	3.52x
P/E ratio	23.22x
P/FCF ratio	16.29x
P/OCF ratio	14.2x
P/S ratio	0.83x
Price / tangible book value	3.57x
Price/EBITDA ratio	12.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.85%
EBITDA margin	6.42%
Effective tax rate	15.54%
FCF margin	5.02%
Gross margin	20.05%
Operating margin	5.85%
Pretax margin	4.38%
Profit margin	3.53%
Profit per employee	CLP 39.6M
Profitable quarters	9
Profitable years	27
Revenue per employee	CLP 1.1B
ROA	5.24%
ROA (5Y)	6.86%
ROCE	13.38%
ROE	15.77%
ROE (5Y)	20.42%
ROIC	12.39%
ROIC (5Y)	14.86%
SBC / revenue	0.23%
Tax / revenue	0.68%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-8.96%
EPS growth (Q)	75.93%
EPS growth (QoQ)	-24.56%
EPS growth 10Y	9.96%
EPS growth 3Y	-8.76%
EPS growth 5Y	1.66%
EPS growth quarters	2
EPS growth years	0
FCF growth	31.4%
FCF growth (Q)	-15.65%
FCF growth (QoQ)	-58.41%
FCF growth 3Y	-4.78%
FCF growth 5Y	-0.06%
Net income growth	-9.69%
Net income growth (Q)	75.04%
Net income growth (QoQ)	-25.05%
Net income growth 3Y	-9.86%
Net income growth 5Y	0.59%
Net income growth quarters	1
Net income growth years	0
OCF growth	24.99%
OCF growth (Q)	-13.83%
OCF growth (QoQ)	-53.65%
OCF growth 10Y	5.94%
OCF growth 3Y	-4.13%
OCF growth 5Y	0.76%
Revenue growth	3.42%
Revenue growth (Q)	-0.41%
Revenue growth (QoQ)	0.59%
Revenue growth 10Y	9.54%
Revenue growth 3Y	7.73%
Revenue growth 5Y	10.01%
Revenue growth quarters	126
Revenue growth years	33

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CLP -3.3T
EBIT	CLP 25.6T
EBITDA	CLP 28.1T
EPS	CLP 17,206.84
Financing cash flow	CLP -15.6T
Free cash flow	CLP 22.2T
Free cash flow minus SBC	CLP 21.2T
Gross profit	CLP 87.8T
Income taxes	CLP 3T
Investing cash flow	CLP -11.1T
Net borrowing	CLP -4.7T
Net cash flow	CLP -1.3T
Net income	CLP 15.5T
Operating cash flow minus SBC	CLP 24.5T
Operating income	CLP 25.6T
Revenue	CLP 437.9T
Stock-based compensation	CLP 991.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CLP 112,311.55
Debt / EBITDA	2.44
Debt / equity	0.7
Debt / FCF	3.26
Interest coverage	6.84
Net cash (debt)	CLP -47.2T
Net cash / market cap	-13.04%
Net debt / EBITDA	1.68
Net debt / equity	0.46
Net debt / FCF	2.12
Piotroski F-Score	6
Shareholders' equity	CLP 102.7T
Tangible book value	CLP 101.3T
Tangible book value per share	CLP 112,311.55
Total assets	CLP 304.3T
Total cash	CLP 27.8T
Total debt	CLP 72.3T
Total liabilities	CLP 201.6T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.43
Current ratio	0.74
Net working capital	CLP -49.1T
Quick ratio	0.42
Working capital	CLP -29.4T

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.98%
Dividend growth	1.77%
Dividend growth (3Y)	11.89%
Dividend growth years	3
Dividend payment date	2026-09-22
Dividend payment years	5
Dividend payout frequency	Quarterly
Dividend per share	CLP 8,313.09
Dividend yield	2.08%
Ex-dividend date	2026-09-14
Last dividend	CLP 2,191.01
Payout ratio	51.45%
Shareholder yield	3.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CLP 342,656.87
1D price change	0%
1M price change	11.15%
1M total return	11.15%
1W price change	7.83%
1W total return	7.83%
1Y price change	13.68%
1Y return CAGR	16.74%
1Y total return	16.73%
20-day SMA	CLP 378,037.50
200-day SMA	CLP 331,742.65
3M price change	-1.36%
3M total return	-0.77%
3Y price change	6.25%
3Y return CAGR	4.23%
3Y total return	13.24%
50-day SMA	CLP 370,219.80
50-day SMA vs 200-day SMA	50over200
52-week high	CLP 405,000.00
52-week high date	2026-07-27
52-week low	CLP 239,660.00
52-week low date	2026-02-04
6M price change	33.61%
6M total return	35.35%
All-time high	CLP 612,630.00
All-time high date	2024-11-11
All-time low	CLP 267.50
All-time low date	2025-07-29
Average true range (ATR)	CLP 1,973.38
Average volume	0
Change from 52-week high	-1.36%
Change from 52-week low	66.69%
Change from all-time high	-34.79%
Change from all-time low	149,245.79%
Monthly RSI	54.89
Previous close	CLP 399,500.00
Price vs 150-day SMA	16.59%
Price vs 20-day SMA	5.68%
Price vs 200-day SMA	20.42%
Price vs 50-day SMA	7.91%
RSI	89.9
Sharpe ratio	0.52
Sharpe ratio (3Y)	0.24
Sortino ratio	1.42
Sortino ratio (3Y)	0.45
Weekly RSI	70.6
YTD price change	33.61%
YTD total return	36.26%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	895M
Shares change (QoQ)	-0.44%
Shares change (YoY)	-0.98%
Shares held by insiders	0.17%
Shares held by institutions	88.98%
Short ratio	2.8 days

Deeper analysis on SNSE/UNHCL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNSE/UNHCL report

Is a complete SNSE/UNHCL research report available?

No complete published report is available for snse/UNHCL (SNSE/UNHCL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SNSE/UNHCL (SNSE/UNHCL)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/UNHCL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/UNHCL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/UNHCL

Frequently asked questions